Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus

Aims To evaluate the safety and efficacy of empagliflozin for 52 weeks as add‐on to one other oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus (T2DM). Methods Patients on biguanide (n = 133), thiazolidinedione (n = 273), α‐glucosidase inhibitor (n = 139), dipeptidyl‐pepti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2015-07, Vol.17 (7), p.665-674
Hauptverfasser:	Araki, E., Tanizawa, Y., Tanaka, Y., Taniguchi, A., Koiwai, K., Kim, G., Salsali, A., Woerle, H. J., Broedl, U. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antidiabetics Benzhydryl Compounds - administration & dosage Benzhydryl Compounds - adverse effects Biguanides - administration & dosage Blood Glucose - analysis Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - administration & dosage Double-Blind Method Drug Therapy, Combination empagliflozin Female Glucosides - administration & dosage Glucosides - adverse effects Glycated Hemoglobin A - analysis Glycoside Hydrolase Inhibitors - administration & dosage Hemoglobin Humans Hypoglycemia - chemically induced Hypoglycemia - epidemiology Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Intervention Japan Male Metformin Metformin - administration & dosage Middle Aged SGLT2 inhibitor Sulfonylurea Compounds - administration & dosage Thiazolidinediones - administration & dosage Treatment Outcome type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!